Anne Poli

Phase 1/1b study of the FAK inhibitor defactinib (VS-6063) in combination with weekly paclitaxel for advanced ovarian cancer.

Manish R. Patel, Jeffrey R. Infante, Kathleen N. Moore et al. · Journal of Clinical Oncology · 2014 · 29 citations

Medicine, Oncology, Pharmacology +17

Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer.

Alberto Riccardi, Carmine Tinelli, Silvia Brugnatelli et al. · International Journal of Oncology · 2000 · 28 citations

Medicine, Oncology, Pharmacology +14

Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics—A phase II multicenter study

Paolo Antognoni, Mario Bignardi, L.F. Cazzaniga et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 25 citations

Medicine, Oncology, Radiation Oncology +11